SciELO - Scientific Electronic Library Online

 
vol.20 número1Influencia de la posición libremente escogida comparada con litotomía durante la atención de parto en los resultados maternos y neonatalesManejo del dolor postoperatorio en cirugía por cáncer de mama índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Acta médica Grupo Ángeles

versión impresa ISSN 1870-7203

Resumen

NAVARRETE HORTA, Teresa; GUERRERO CARRENO, Francisco Javier; VALDES AGUERREBERE, Paulina  y  VAZQUEZ ESTRADA, Leopoldo Alejandro. Estetrol: a new paradigm in gynecological therapy?. Acta méd. Grupo Ángeles [online]. 2022, vol.20, n.1, pp.50-57.  Epub 10-Oct-2022. ISSN 1870-7203.  https://doi.org/10.35366/103556.

Estetrol (E4) is a natural estrogen produced by the human fetus and passes into the maternal blood at relatively high levels during pregnancy. Over the past two decades, its pharmacodynamic and pharmacokinetic profiles, tolerability, and safety margin have been shown to be highly favorable. In this sense, E4 potentially represents a great advance in gynecological therapy such as contraception and the management of menopause. E4 also shows applicability in other therapeutic fields such as hormone-dependent cancers (breast and prostate), osteoporosis, neuroprotection, muscle pain, and wound healing. We present hereinafter the current evidence on this “new” hormonal therapy option whose inclusion in gynecological clinical practice seems imminent.

Palabras llave : Estetrol; E4; contraception; menopause; hormonal therapy.

        · resumen en Español     · texto en Español